Prediction Case File
YouTubeEvaluation Complete

UnitedHealth shares are up significantly since I upgraded the stock to a buy rating.

1 extracted signal · 1 resolved · 0 still active

Parkev Tatevosian, CFA profile imageParkev Tatevosian, CFAIndependent analyst profile
Source published
08 Oct 2025, 17:45 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for UnitedHealth shares are up significantly since I upgraded the stock to a buy rating.
Source overview

AI-generated source summary

The analyst discusses United Health stock, mentioning he previously rated it a buy between 270 and 235. The stock price has since increased to 359. He refers to Fiscal AI, noting the forward P/E ratio is now 22, up from lows of 13-14 earlier in 2025. He mentions that underperformance in 2025 was due to company estimate mistakes regarding the cost to serve their customers. He uses proprietary discounted cash flow valuations, with the model showing an intrinsic value of 449.17 per share. The analysis emphasizes a decade of free cash flow estimates and a weighted average cost of capital with the balance sheet. He still likes the risk reward profile at current market prices.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

Parkev Tatevosian, CFA

Platform-wide history, separate from this source evaluation.

Reliability
41.8
Tracked signals
1293
Historical success
25.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail